Rezultati - Pierre‐Emmanuel Morange

Refine Results
  1. 1
    Current knowledge on the genetics of incident venous thrombosis

    Current knowledge on the genetics of incident venous thrombosis od Pierre‐Emmanuel Morange, David‐Alexandre Trégouët

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

    What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies od David‐Alexandre Trégouët, Pierre‐Emmanuel Morange

    Izdano 2017
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

    Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk od I. Juhan-Vague, Marie‐Christine Alessi, Alenka Mavri, Pierre‐Emmanuel Morange

    Izdano 2003
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral‐ or bacterial‐oriented immune responses

    Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral‐ or bacterial‐oriented immune responses od P Bourgoin, Géraldine Biéchelé, Inès Ait Belkacem, Pierre‐Emmanuel Morange, Fabrice Malergue

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells

    miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells od Alexandre Marchand, Carole Proust, Pierre‐Emmanuel Morange, Anne‐Marie Lompré, David‐Alexandre Trégouët

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies

    Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies od Hugues Aschard, Bjarni J. Vilhjálmsson, Nicolas Greliche, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, Peter Kraft

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level

    PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level od Pierre‐Emmanuel Morange, Marie‐Christine Alessi, Monique Verdier, Daniel Casanova, G. Magalon, I. Juhan‐Vague

    Izdano 1999
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity

    Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity od Pierre‐Emmanuel Morange, H.R. Lijnen, Marie‐Christine Alessi, F Kopp, D Collen, I. Juhan‐Vague

    Izdano 2000
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

    High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronar... od T. Cuisset, Corinne Frère, Jacques Quilici, Franck Barbou, Pierre‐Emmanuel Morange, Thomas Hovasse, J‐L. BONNET, Marie‐Christine Alessi

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors

    Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors od I. Juhan-Vague, Jean‐François Renucci, M. Grimaux, Pierre‐Emmanuel Morange, J. Gouvernet, Y Gourmelin, Marie‐Christine Alessi

    Izdano 2000
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat

    Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat od Delphine Bastelica, Pierre‐Emmanuel Morange, B Berthet, Hélène Borghi, Odile Lacroix, Michel Grino, I. Juhan‐Vague, Marie‐Christine Alessi

    Izdano 2002
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

    Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. od Marie‐Christine Alessi, Delphine Bastelica, Pierre‐Emmanuel Morange, B Berthet, Isabelle Leduc, Monique Verdier, O Geel, I. Juhan-Vague

    Izdano 2000
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies

    The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies od Jessica Dennis, Candice Y. Johnson, Adeniyi Samuel Adediran, Mariza de Andrade, John A. Heit, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, France Gagnon

    Izdano 2012
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting

    Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary S... od Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Lyassine Nait-Saïdi, Joseph Carvajal, Agnès Lehmann, M. Lambert, J Bonnet, Marie‐Christine Alessi

    Izdano 2006
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort

    Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort od Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, Corinne Frère, Noémie Saut, Laurence Pellegrina, Marie‐Christine Alessi, Sophie Visvikis‐Siest, Laurence Tiret, I. Juhan‐Vague

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

    Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels od Guillemette Antoni, Tiphaine Oudot‐Mellakh, Apostolos Dimitromanolakis, Marine Germain, William Cohen, Philip Wells, Mark Lathrop, France Gagnon, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët

    Izdano 2011
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Plasma Biomarkers and Identification of Resilient Metabolic Disruptions in Patients With Venous Thromboembolism Using a Metabolic Systems Approach

    Plasma Biomarkers and Identification of Resilient Metabolic Disruptions in Patients With Venous Thromboembolism Using a Metabolic Systems Approach od Karl Fraser, Nicole C. Roy, Louisa Goumidi, Alexandre Verdu, Pierre Suchon, Felipe L. Valentim, David‐Alexandre Trégouët, Pierre‐Emmanuel Morange, Jean‐Charles Martin

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study

    TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study od Pierre‐Emmanuel Morange, Laurence Tiret, Noémie Saut, G. Luc, Dominique Arveiler, Jean Ferrières, Philippe Amouyel, A. Evans, Pierre Ducimetière, François Cambien, I. Juhan‐Vague

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment

    Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment od José Manuel Soria, Pierre‐Emmanuel Morange, Joan Vila, Juan Carlos Souto, Manel Moyano, David‐Alexandre Trégouët, José Mateo, Noémi Saut, Eduardo Salas, Roberto Elosúa

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders

    Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders od Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Jean-Philippe Mouret, Laurent Bali, Pierre-Julien Moro, M. Lambert, Marie‐Christine Alessi, Jean Louis Bonnet

    Izdano 2008
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: